HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Fines L’Occitane For “Slimming” Claims, Calls For Media “Gut Check”

This article was originally published in The Rose Sheet

Executive Summary

FTC settles with L’Occitane and three marketers of weight-loss products and launches its “gut check” voluntary media partnership program to help prevent bogus claims. Settlements with the four marketers totaled $33 million.

You may also be interested in...



Family Business Making Cancer, HIV Claims Sent To FTC Time-Out

FTC and supplement marketer NextGen Nutritionals reach a $1.3m settlement over claims the firm made for products including hoodia. The order stipulates the firm discontinue making “gut-check” claims and using false testimonials and certification seals.

Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities

Dubious supplement ad claims that have driven FTC enforcement in the sector for some time likely will continue as three commission seats are filled, says advertising practices official Richard Cleland.

In Brief: N.J. Bans Microbeads; Prestige Device Sales; Direct Sellers Merge

New Jersey becomes the second state that will prohibit the production and sale of microbeads, as Gov. Chris Christie signs into law a bill that closely follow’s Illinois’ industry-backed legislation. More news in brief.

Related Content

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

RS019025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel